Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

Inflammatory Bowel Disease Excellence Forum

Inflammatory Bowel Disease
Excellence Forum
Leaders in the field sharing authoritative insights and institutional best practices.

Uni Wong
Conference Coverage
Uni Wong, MD, on What’s New in Biosimilars in 2022
04/05/2022
Biosimilars appear to be fully as safe and effective for management of inflammatory disease as their reference products, Dr Wong, from the IBD Center at the University of Maryland School of Medicine, explained at the Advances in Inflammatory...
Biosimilars appear to be fully as safe and effective for management of inflammatory disease as their reference products, Dr Wong, from the IBD Center at the University of Maryland School of Medicine, explained at the Advances in Inflammatory...
Biosimilars appear to be fully...
04/05/2022
Advances in Inflammatory Bowel Disease Network
Dr Ali
Q&A
Tauseef Ali, MD, on #RespectMyPrescription
04/05/2022
Tauseef Ali, MD, with SSM Health Medical Group in Oklahoma City, Oklahoma, is turning to the power of social media to call out health insurers who delay care for patients with inflammatory bowel disease.
Tauseef Ali, MD, with SSM Health Medical Group in Oklahoma City, Oklahoma, is turning to the power of social media to call out health insurers who delay care for patients with inflammatory bowel disease.
Tauseef Ali, MD, with SSM Health...
04/05/2022
Advances in Inflammatory Bowel Disease Network
Hudesman
Video
David Hudesman, MD, on What's New in First-Line Therapy in 2022
04/04/2022
Dr Hudesman, from NYU Langone Health, discusses his talk from the Advances in Inflammatory Bowel Disease regional meeting on new therapies and combinations available for treating IBD.
Dr Hudesman, from NYU Langone Health, discusses his talk from the Advances in Inflammatory Bowel Disease regional meeting on new therapies and combinations available for treating IBD.
Dr Hudesman, from NYU Langone...
04/04/2022
Advances in Inflammatory Bowel Disease Network
Millie Long, MD
Videos
Millie Long, MD, on the Evolution of Evidence-Based Management of IBD
04/02/2022
Dr Long gives an overview of her keynote address at the AIBD 2022 Regionals Meeting in Raleigh, North Carolina, where she looked back at the past 20 years of evidence-based IBD management and mapped out what the future could look like for the...
Dr Long gives an overview of her keynote address at the AIBD 2022 Regionals Meeting in Raleigh, North Carolina, where she looked back at the past 20 years of evidence-based IBD management and mapped out what the future could look like for the...
Dr Long gives an overview of her...
04/02/2022
Advances in Inflammatory Bowel Disease Network
Sara Horst
Video
Sara Horst, MD, on IL-12/23 and IL-23 Receptor Antagonists for Treatment of IBD
04/02/2022
Dr Horst, from Vanderbilt Medical Center, recaps her presentation from the Advances in Inflammatory Bowel Diseases regional meeting on using IL-12/23 and IL-23 receptor antagonists in treating IBD.
Dr Horst, from Vanderbilt Medical Center, recaps her presentation from the Advances in Inflammatory Bowel Diseases regional meeting on using IL-12/23 and IL-23 receptor antagonists in treating IBD.
Dr Horst, from Vanderbilt...
04/02/2022
Advances in Inflammatory Bowel Disease Network
Kim Isaacs, MD
Conference Coverage
Kim Isaacs, MD, on Treating Acute Severe Ulcerative Colitis
04/02/2022
At the AIBD 2022 Regional Meeting in Raleigh, NC on April 2, Dr Kim Isaacs gave an overview of acute severe ulcerative colitis: how to recognize it, what comorbidities to be aware of, and how to treat it.
At the AIBD 2022 Regional Meeting in Raleigh, NC on April 2, Dr Kim Isaacs gave an overview of acute severe ulcerative colitis: how to recognize it, what comorbidities to be aware of, and how to treat it.
At the AIBD 2022 Regional...
04/02/2022
Advances in Inflammatory Bowel Disease Network
Herfarth
Conference Coverage
Hans Herfarth, MD, on Ulcerative Colitis in 2022
04/02/2022
Dr Herfarth, from the University of North Carolina at Chapel Hill, reviewed guidance on the treatment of ulcerative colitis, and the expanding number of therapies available, in his presentation at the Advances in Inflammatory Bowel Diseases...
Dr Herfarth, from the University of North Carolina at Chapel Hill, reviewed guidance on the treatment of ulcerative colitis, and the expanding number of therapies available, in his presentation at the Advances in Inflammatory Bowel Diseases...
Dr Herfarth, from the University...
04/02/2022
Advances in Inflammatory Bowel Disease Network
Raymond Cross, MD
Videos
Raymond Cross, MD, on Leukocyte Trafficking
04/02/2022
Dr Cross reviews his presentation on leukocyte trafficking in treatment for inflammatory bowel disease from the Advances in Inflammatory Bowel Disease Regional Meeting on April 2, 2022.
Dr Cross reviews his presentation on leukocyte trafficking in treatment for inflammatory bowel disease from the Advances in Inflammatory Bowel Disease Regional Meeting on April 2, 2022.
Dr Cross reviews his...
04/02/2022
Advances in Inflammatory Bowel Disease Network
Wong
Conference Coverage
Uni Wong, MD, on Complicated Crohn Disease in 2022
04/02/2022
Dr Wong, from the University of Maryland School of Medicine, explains the complications that can occur with Crohn disease and methods for prevention and treatment.
Dr Wong, from the University of Maryland School of Medicine, explains the complications that can occur with Crohn disease and methods for prevention and treatment.
Dr Wong, from the University of...
04/02/2022
Advances in Inflammatory Bowel Disease Network
Sara Horst
Video
Sara Horst, MD, on Risk Stratification and Disease Monitoring for Patients With IBD
04/02/2022
Dr Horst, from Vanderbilt University Medical Center, reviews her presentation from the Advances in Inflammatory Bowel Diseases regional meeting about how risk stratification and disease monitoring can improve outcomes among patients with IBD.
Dr Horst, from Vanderbilt University Medical Center, reviews her presentation from the Advances in Inflammatory Bowel Diseases regional meeting about how risk stratification and disease monitoring can improve outcomes among patients with IBD.
Dr Horst, from Vanderbilt...
04/02/2022
Advances in Inflammatory Bowel Disease Network

Advertisement

Latest News

Uma Mahadevan, MD
Conference Coverage
Uma Mahadevan, MD, on Managing Pregnancy Among Patients With IBD
12/07/2022
Uma Mahadevan, MD, one this year's Sherman Prize winners, addressed concerns in the management of inflammatory bowel diseases among pregnant women and her research into the safety of IBD medications as demonstrated by the PIANO study.
Uma Mahadevan, MD, one this year's Sherman Prize winners, addressed concerns in the management of inflammatory bowel diseases among pregnant women and her research into the safety of IBD medications as demonstrated by the PIANO study.
Uma Mahadevan, MD, one this...
12/07/2022
Advances in Inflammatory Bowel Disease Network
Ryan Ungaro
Conference Coverage
Managing Viral Infections Among Patients with IBD
12/06/2022
Ryan Ungaro, MD, MS, from the Icahn School of Medicine at Mount Sinai at New York, led a panel discussion with colleagues to review the complex relationship between viruses and inflammatory bowel diseases and the challenges of providing...
Ryan Ungaro, MD, MS, from the Icahn School of Medicine at Mount Sinai at New York, led a panel discussion with colleagues to review the complex relationship between viruses and inflammatory bowel diseases and the challenges of providing...
Ryan Ungaro, MD, MS, from the...
12/06/2022
Advances in Inflammatory Bowel Disease Network
News
Rubin, Wu, and Allegretti Named Sherman Prize Winners
11/11/2020
The Bruce and Cynthia Sherman Charitable Foundation will present the 2020 Sherman Prizes and Sherman Emerging Leader Prize to David T. Rubin, MD; Gary D. Wu, MD; and Jessica Allegretti, MD, at the Advances in Inflammatory Bowel Diseases...
The Bruce and Cynthia Sherman Charitable Foundation will present the 2020 Sherman Prizes and Sherman Emerging Leader Prize to David T. Rubin, MD; Gary D. Wu, MD; and Jessica Allegretti, MD, at the Advances in Inflammatory Bowel Diseases...
The Bruce and Cynthia Sherman...
11/11/2020
Advances in Inflammatory Bowel Disease Network
News
The Role of Diet- and Microbial-Based Therapies in IBD
09/30/2020
Patients with inflammatory bowel disease often ask for advice on diets, supplements, and other therapies. Kerri Glassner, DO, discussed the evidence for such interventions at the Advances in Inflammatory Bowel Disease virtual regional meeting...
Patients with inflammatory bowel disease often ask for advice on diets, supplements, and other therapies. Kerri Glassner, DO, discussed the evidence for such interventions at the Advances in Inflammatory Bowel Disease virtual regional meeting...
Patients with inflammatory bowel...
09/30/2020
Advances in Inflammatory Bowel Disease Network
News
Diagnosis, Management, and Prevention of Recurrent C diff in Patients With IBD
09/30/2020
Patients with Crohn disease and ulcerative colitis are significantly more likely to contract Clostridioides difficile than the general population. Andrew DuPont, MD, explained how to diagnose, treat, and prevent recurrence of this serious...
Patients with Crohn disease and ulcerative colitis are significantly more likely to contract Clostridioides difficile than the general population. Andrew DuPont, MD, explained how to diagnose, treat, and prevent recurrence of this serious...
Patients with Crohn disease and...
09/30/2020
Advances in Inflammatory Bowel Disease Network
News
Pregnancy in the IBD Pathway
09/12/2020
Working with patients with inflammatory bowel disease who are or wish to become pregnant presents special challenges. Kim Isaacs, MD, shared her insights at the virtual Advances in Inflammatory Bowel Disease regional meeting on September 12.
Working with patients with inflammatory bowel disease who are or wish to become pregnant presents special challenges. Kim Isaacs, MD, shared her insights at the virtual Advances in Inflammatory Bowel Disease regional meeting on September 12.
Working with patients with...
09/12/2020
Advances in Inflammatory Bowel Disease Network
News
Framing the Switch to Biosimilars for Patients and Providers
08/30/2020
Biosimilars show promise in reducing costs and equaling efficacy, compared with originator compounds. But will they live up to that potential? Russell Cohen, MD, addressed these issues and more at the Advances in Inflammatory Bowel Disease...
Biosimilars show promise in reducing costs and equaling efficacy, compared with originator compounds. But will they live up to that potential? Russell Cohen, MD, addressed these issues and more at the Advances in Inflammatory Bowel Disease...
Biosimilars show promise in...
08/30/2020
Advances in Inflammatory Bowel Disease Network
News
Ustekinumab Shows Superior Persistance in CD Patients With Prior Biologic Use
08/26/2024
When used after a first-line agent, ustekinumab had significantly better persistence than other biologics.
When used after a first-line agent, ustekinumab had significantly better persistence than other biologics.
When used after a first-line...
08/26/2024
Advances in Inflammatory Bowel Disease Network
News
Upadacitinib Provides Rapid Response in Crohn's Disease
08/12/2024
Pooled data from induction trials showed improvement in symptoms of Crohn’s disease within a week.
Pooled data from induction trials showed improvement in symptoms of Crohn’s disease within a week.
Pooled data from induction...
08/12/2024
Advances in Inflammatory Bowel Disease Network
News
Colorectal Cancer Risk Higher Among Patients WIth PSC, With or Without IBD
07/24/2024
Extended screening and surveillance are recommended for all patients with primary sclerosing cholangitis, but those with comorbid inflammatory bowel disease are at highest risk.
Extended screening and surveillance are recommended for all patients with primary sclerosing cholangitis, but those with comorbid inflammatory bowel disease are at highest risk.
Extended screening and...
07/24/2024
Gastroenterology
News
Biomarker Study Finds ‘Clearcut’ Case for Early Advanced Therapy for CD
05/24/2024

Jolynn Tumolo

Jolynn Tumolo
Top-down therapy significantly outperforms step-up treatment for Crohn’s disease with fewer adverse events.
Top-down therapy significantly outperforms step-up treatment for Crohn’s disease with fewer adverse events.
Top-down therapy significantly...
05/24/2024
Advances in Inflammatory Bowel Disease Network
fecal calprotectin test
News
Fecal Calprotectin: Effective Marker In Understanding Progression of Crohn's Disease
05/09/2024

Priyam Vora, Associate Editor

Priyam Vora, Associate Editor
Evidence shows the value of fecal calprotectin to better understand the trajectory of Crohn's disease.
Evidence shows the value of fecal calprotectin to better understand the trajectory of Crohn's disease.
Evidence shows the value of...
05/09/2024
Advances in Inflammatory Bowel Disease Network
News
Study Finds Higher-Than-Expected IBD Rates in US Black Women
05/02/2024

Jolynn Tumolo

Jolynn Tumolo
The incidence of inflammatory bowel disease was highest among Black women younger than 30 years of age.
The incidence of inflammatory bowel disease was highest among Black women younger than 30 years of age.
The incidence of inflammatory...
05/02/2024
Advances in Inflammatory Bowel Disease Network
FDA alert
FDA Alert
FDA Approves Subcutaneous Vedolizumab for Maintenance Therapy in Crohn’s Disease
04/22/2024
The US Food and Drug Administration approved a subcutaneous formulation of vedolizumab for moderate to severe Crohn's disease.
The US Food and Drug Administration approved a subcutaneous formulation of vedolizumab for moderate to severe Crohn's disease.
The US Food and Drug...
04/22/2024
Advances in Inflammatory Bowel Disease Network
Bharati Kochar
Conference Coverage
Bharati Kochar, MD, on Comparative Effectiveness in Positioning Therapies in Ulcerative Colitis
04/10/2024
Dr Bharati Kochar talks about considering the efficacy-safety relationship to avoid longstanding corticosteroid use or the use of less effective agents in biologic-exposed populations at the AIBD regional meeting in Boston.
Dr Bharati Kochar talks about considering the efficacy-safety relationship to avoid longstanding corticosteroid use or the use of less effective agents in biologic-exposed populations at the AIBD regional meeting in Boston.
Dr Bharati Kochar talks about...
04/10/2024
Advances in Inflammatory Bowel Disease Network
News
Post-Menopausal Women With IBD and Hormone Replacement Therapy
04/05/2024

Priyam Vora, Associate Editor

Priyam Vora, Associate Editor
Investigators sought to determine the effects of hormone replacement therapy on disease activity among post-menopausal women with IBD.
Investigators sought to determine the effects of hormone replacement therapy on disease activity among post-menopausal women with IBD.
Investigators sought to...
04/05/2024
Advances in Inflammatory Bowel Disease Network
News
Extended Mirikizumab Induction Benefits Slower Responders in UC Trials
03/20/2024

Jolynn Tumolo

Jolynn Tumolo
LUCENT trials found that 24-week induction period generated response in half of patients.
LUCENT trials found that 24-week induction period generated response in half of patients.
LUCENT trials found that 24-week...
03/20/2024
Advances in Inflammatory Bowel Disease Network

Advertisement

Latest Podcasts

IBD Drive time logo
Podcast
IBD Drive Time: Best of DDW, Part 1
07/09/2024
In the first episode of this two-part series, Dr Raymond Cross of Mercy Medical Center reviews his top picks for the best abstracts on inflammatory bowel disease presented at this year's Digestive Disease Week with cohost Dr Millie Long of...
In the first episode of this two-part series, Dr Raymond Cross of Mercy Medical Center reviews his top picks for the best abstracts on inflammatory bowel disease presented at this year's Digestive Disease Week with cohost Dr Millie Long of...
In the first episode of this...
07/09/2024
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: Gary Lichtenstein, MD, on the Best of ECCO
05/06/2024
IBD Drive Time continues its coverage of the European Crohn's & Colitis Organization meeting as Dr Gary Lichtenstein shares his choices on the best abstracts with host Dr Raymond Cross.
IBD Drive Time continues its coverage of the European Crohn's & Colitis Organization meeting as Dr Gary Lichtenstein shares his choices on the best abstracts with host Dr Raymond Cross.
IBD Drive Time continues its...
05/06/2024
Advances in Inflammatory Bowel Disease Network
Dr Lea Ann Chen
Podcast
Lea Ann Chen, MD Explains Manifestations of IBD Based on Race and Immigration Status
02/06/2024
In this podcast, Dr Lea Ann Chen explains how race/ ethnicity (White, Black, Hispanic, Asian) and immigration status (US-born vs foreign-born) influence IBD manifestations, disease onset, treatments, and outcomes.
In this podcast, Dr Lea Ann Chen explains how race/ ethnicity (White, Black, Hispanic, Asian) and immigration status (US-born vs foreign-born) influence IBD manifestations, disease onset, treatments, and outcomes.
In this podcast, Dr Lea Ann Chen...
02/06/2024
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD DriveTime: Francis Farraye, MD, on Vaccines for Patients With IBD
11/08/2023
Dr Raymond Cross quizzes Dr Francis Farraye on the latest guidance regarding vaccinations against COVID-19 and RSV in this episode of IBD DriveTime.
Dr Raymond Cross quizzes Dr Francis Farraye on the latest guidance regarding vaccinations against COVID-19 and RSV in this episode of IBD DriveTime.
Dr Raymond Cross quizzes Dr...
11/08/2023
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: Ethical Issues in Clinical Trials
10/18/2023
In this episode of IBD Drive Time, guest host David Rubin, MD, calls on Drs Severine Vermeire of KU Leuven University in Belgium and Dan Tucker of Hebrew University of Jerusalem to talk about the challenges of recruiting patients for clinical...
In this episode of IBD Drive Time, guest host David Rubin, MD, calls on Drs Severine Vermeire of KU Leuven University in Belgium and Dan Tucker of Hebrew University of Jerusalem to talk about the challenges of recruiting patients for clinical...
In this episode of IBD Drive...
10/18/2023
Advances in Inflammatory Bowel Disease Network
Podcast
Frank Scott, MD, on Creation of an IBD Referral Pathway
10/11/2023
Dr Scott, from the University of Colorado Health Sciences Center, discusses the development of a referral pathway based on specific diagnostic criteria that indicate the need to refer patients with inflammatory bowel disease to specialist...
Dr Scott, from the University of Colorado Health Sciences Center, discusses the development of a referral pathway based on specific diagnostic criteria that indicate the need to refer patients with inflammatory bowel disease to specialist...
Dr Scott, from the University of...
10/11/2023
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: Michael Dolinger, MD, on Using Intestinal Ultrasound
10/04/2023
Guest Michael Dolinger, MD, from the Icahn School of Medicine at Mount Sinai, talks to host Millie Long, MD, about the use and advantages of intestinal ultrasound for monitoring inflammatory bowel disease.
Guest Michael Dolinger, MD, from the Icahn School of Medicine at Mount Sinai, talks to host Millie Long, MD, about the use and advantages of intestinal ultrasound for monitoring inflammatory bowel disease.
Guest Michael Dolinger, MD, from...
10/04/2023
Advances in Inflammatory Bowel Disease Network
IBD Drive Time Logo
Podcast
IBD Drive Time: Upadacitinib Therapy for Crohn’s Disease
09/05/2023

featuring Edward Loftus, MD

featuring Edward Loftus, MD
Dr Edward Loftus reviews details of the pivotal trial where upadacitinib emerged a superior alternative to placebo for induction and maintenance therapy among patients with moderate-to-severe Crohn’s disease.
Dr Edward Loftus reviews details of the pivotal trial where upadacitinib emerged a superior alternative to placebo for induction and maintenance therapy among patients with moderate-to-severe Crohn’s disease.
Dr Edward Loftus reviews details...
09/05/2023
Advances in Inflammatory Bowel Disease Network
Adam Faye, MD, MS
News
"Prehabilitation” for Older Patients Helps Reduce Complications of IBD Surgery
08/31/2023

featuring Adam Faye, MD, MS

featuring Adam Faye, MD, MS
In this podcast, Dr Adam Faye explains the association between various patient-level demographic, nutritional and clinical factors and risk for complications among older patients who underwent intestinal resection for inflammatory bowel...
In this podcast, Dr Adam Faye explains the association between various patient-level demographic, nutritional and clinical factors and risk for complications among older patients who underwent intestinal resection for inflammatory bowel...
In this podcast, Dr Adam Faye...
08/31/2023
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
Gil Melmed, MD, on Health Maintenance for Patients With IBD
08/29/2023
Dr Gil Melmed from Cedars-Sinai talks with Drs Raymond Cross and Millie Long about the importance of vaccines, cancer screenings, and other aspects of overall health maintenance for patients with inflammatory bowel disease.
Dr Gil Melmed from Cedars-Sinai talks with Drs Raymond Cross and Millie Long about the importance of vaccines, cancer screenings, and other aspects of overall health maintenance for patients with inflammatory bowel disease.
Dr Gil Melmed from Cedars-Sinai...
08/29/2023
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: Dr Jana Al Hashash on Diet and Nutrition in IBD Care
08/05/2024
Dr Jana Al Hashash from Mayo Clinic—Florida offers guidance on how diet can affect IBD and the best approaches to maintaining adequate nutrition, along with hosts Millie Long, MD, and Raymond Cross, MD.
Dr Jana Al Hashash from Mayo Clinic—Florida offers guidance on how diet can affect IBD and the best approaches to maintaining adequate nutrition, along with hosts Millie Long, MD, and Raymond Cross, MD.
Dr Jana Al Hashash from Mayo...
08/05/2024
Advances in Inflammatory Bowel Disease Network
Shubha Bhat
Podcast
Shubha Bhat, PharmD, on the Role of the Clinical Pharmacist in IBD
07/25/2024
Dr Bhat reports on the recent systematic review and RAND consensus process to define the role of the clinical pharmacist in caring for patients with inflammatory bowel disease.
Dr Bhat reports on the recent systematic review and RAND consensus process to define the role of the clinical pharmacist in caring for patients with inflammatory bowel disease.
Dr Bhat reports on the recent...
07/25/2024
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: The Best of DDW, Part 2
07/18/2024
In part 2 of this podcast, cohost Dr Millie Long discusses her picks for the "Best of DDW" on inflammatory bowel disease with her cohost, Dr Ray Cross.
In part 2 of this podcast, cohost Dr Millie Long discusses her picks for the "Best of DDW" on inflammatory bowel disease with her cohost, Dr Ray Cross.
In part 2 of this podcast,...
07/18/2024
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: Best of DDW, Part 1
07/09/2024
In the first episode of this two-part series, Dr Raymond Cross of Mercy Medical Center reviews his top picks for the best abstracts on inflammatory bowel disease presented at this year's Digestive Disease Week with cohost Dr Millie Long of...
In the first episode of this two-part series, Dr Raymond Cross of Mercy Medical Center reviews his top picks for the best abstracts on inflammatory bowel disease presented at this year's Digestive Disease Week with cohost Dr Millie Long of...
In the first episode of this...
07/09/2024
Advances in Inflammatory Bowel Disease Network
Millie Long
Video
Millie Long, MD, on Comparative Effectiveness in Ulcerative Colitis
06/24/2024
Dr Long reviews her presentation from the AIBD regional meeting on using comparative effectiveness data to choose from among the growing number of therapies for treating ulcerative colitis.
Dr Long reviews her presentation from the AIBD regional meeting on using comparative effectiveness data to choose from among the growing number of therapies for treating ulcerative colitis.
Dr Long reviews her presentation...
06/24/2024
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: The Best of ECCO With Dr Frank Farraye
06/12/2024
Dr Frank Farraye, director of the IBD Center at Mayo Jacksonville, joins IBD Drive Time hosts Millie Long, MD, and Raymond Cross, MD, to review the best of presentations on the natural history of IBD at the European Crohn's & Colitis...
Dr Frank Farraye, director of the IBD Center at Mayo Jacksonville, joins IBD Drive Time hosts Millie Long, MD, and Raymond Cross, MD, to review the best of presentations on the natural history of IBD at the European Crohn's & Colitis...
Dr Frank Farraye, director of...
06/12/2024
Advances in Inflammatory Bowel Disease Network
Rishika Chugh
Podcast
Rishika Chugh, MD: Safety of Vedolizumab and Ustekinumab in Pregnancy
05/28/2024
Dr Chugh reviews the results of a recent study of the safety of ustekinumab and vedolizumab among pregnant patients with inflammatory bowel disease.
Dr Chugh reviews the results of a recent study of the safety of ustekinumab and vedolizumab among pregnant patients with inflammatory bowel disease.
Dr Chugh reviews the results of...
05/28/2024
Advances in Inflammatory Bowel Disease Network
Noa Cleveland
Podcast
Noa Krugliak Cleveland, MD, on Intestinal Ultrasound in Clinical Practice
05/22/2024
Dr Krugliak Cleveland reviews the results of research and real-world experience in using intestinal ultrasound in clinical practice when diagnosing and monitoring inflammatory bowel disease.
Dr Krugliak Cleveland reviews the results of research and real-world experience in using intestinal ultrasound in clinical practice when diagnosing and monitoring inflammatory bowel disease.
Dr Krugliak Cleveland reviews...
05/22/2024
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: Gary Lichtenstein, MD, on the Best of ECCO
05/06/2024
IBD Drive Time continues its coverage of the European Crohn's & Colitis Organization meeting as Dr Gary Lichtenstein shares his choices on the best abstracts with host Dr Raymond Cross.
IBD Drive Time continues its coverage of the European Crohn's & Colitis Organization meeting as Dr Gary Lichtenstein shares his choices on the best abstracts with host Dr Raymond Cross.
IBD Drive Time continues its...
05/06/2024
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
Siddharth Singh: AGA Guidelines on Using Biomarkers in Ulcerative Colitis
04/25/2024
In this episode of IBD Drive Time, cohost Raymond Cross, MD, talks with Siddharth Singh, MD, about the latest guidelines from the American Gastroenterological Association on caring for patients with ulcerative colitis.
In this episode of IBD Drive Time, cohost Raymond Cross, MD, talks with Siddharth Singh, MD, about the latest guidelines from the American Gastroenterological Association on caring for patients with ulcerative colitis.
In this episode of IBD Drive...
04/25/2024
Advances in Inflammatory Bowel Disease Network

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Privacy Policy Terms of Use

Advertisement

Advertisement